Kifunensine-13C2 ,15N

• CAT Number: R022437
• CAS Number: NA
• Molecular Formula: C₆¹³C₂H₁₂N¹⁵NO₆
• Molecular Weight: 235.17
• Purity: ≥95%
• Synonyms: [5R-(5α,6β,7α,8α,8aα)]-Hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-imidazo[1,2-a]pyridine-2,3-dione-13C2 ,15N; (+)-Kifunensine-13C2 ,15N; FR 900494-13C2 ,15N
• Storage: -20°C
• IUPAC Name: (5R,6R,7S,8R,8aS)-6,7,8-trihydroxy-5-(hydroxymethyl)-1,5,6,7,8,8a-hexahydro(4,5-13C2,315N)imidazolo[1,2-a]pyridine-2,3-dione
• InChI: InChI=1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5+,6+/m1/s1/i7+1,8+1,9+1
• InChIKey: OIURYJWYVIAOCW-BWRRVPNVSA-N
• SMILES: C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H]2N1[13C](=O)[13C](=O)[15NH]2)O)O)O)O

Kifunensine-13C2,15N, a stable isotopically labeled derivative of kifunensine, is used in biochemical and pharmaceutical research to investigate glycoprotein biosynthesis and protein glycosylation pathways. The 13C and 15N labels enable precise tracking and quantification of kifunensine within biological systems through techniques such as NMR and mass spectrometry. This compound is particularly valuable in studying enzyme activity and substrate interactions in glycobiology. Its applications extend to drug development and understanding the role of glycosylation in disease mechanisms and therapeutic interventions.